113 related articles for article (PubMed ID: 16112587)
1. Striatal D2 receptor binding as a marker of prognosis and outcome in untreated first-episode psychosis.
Corripio I; Pérez V; Catafau AM; Mena E; Carrió I; Alvarez E
Neuroimage; 2006 Jan; 29(2):662-6. PubMed ID: 16112587
[TBL] [Abstract][Full Text] [Related]
2. Density of striatal D2 receptors in untreated first-episode psychosis: an I123-IBZM SPECT study.
Corripio I; Escartí MJ; Portella MJ; Pérez V; Grasa E; Sauras RB; Alonso A; Safont G; Camacho MV; Dueñas R; Arranz B; San L; Catafau AM; Carrió I; Alvarez E
Eur Neuropsychopharmacol; 2011 Dec; 21(12):861-6. PubMed ID: 21470832
[TBL] [Abstract][Full Text] [Related]
3. Striatal dopaminergic D2 receptor occupancy and clinical efficacy in psychosis exacerbation: a 123I-IBZM study with ziprasidone and haloperidol.
Corripio I; Catafau AM; Perez V; Puigdemont D; Mena E; Aguilar Y; Carrió I; Alvarez E
Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jan; 29(1):91-6. PubMed ID: 15610950
[TBL] [Abstract][Full Text] [Related]
4. Cannabis use and striatal D2 receptor density in untreated first-episode psychosis: an in vivo SPECT study.
Safont G; Corripio I; Escartí MJ; Portella MJ; Pérez V; Ferrer M; Camacho V; Sauras RB; Alonso A; Grasa EM; Arranz B; San L; Dueñas R; Carrió I; Álvarez E
Schizophr Res; 2011 Jul; 129(2-3):169-71. PubMed ID: 21459559
[TBL] [Abstract][Full Text] [Related]
5. IBZM SPECT imaging of striatal dopamine-2 receptors in psychotic patients treated with the novel antipsychotic substance quetiapine in comparison to clozapine and haloperidol.
Küfferle B; Tauscher J; Asenbaum S; Vesely C; Podreka I; Brücke T; Kasper S
Psychopharmacology (Berl); 1997 Oct; 133(4):323-8. PubMed ID: 9372530
[TBL] [Abstract][Full Text] [Related]
6. Dopamine D2 receptor blockade in vivo with the novel antipsychotics risperidone and remoxipride--an 123I-IBZM single photon emission tomography (SPET) study.
Busatto GF; Pilowsky LS; Costa DC; Ell PJ; Verhoeff NP; Kerwin RW
Psychopharmacology (Berl); 1995 Jan; 117(1):55-61. PubMed ID: 7536945
[TBL] [Abstract][Full Text] [Related]
7. [123I]IBZM SPECT for imaging of striatal D2 dopamine receptors in 56 schizophrenic patients taking various neuroleptics.
Klemm E; Grünwald F; Kasper S; Menzel C; Broich K; Danos P; Reichmann K; Krappel C; Rieker O; Briele B; Hotze AL; Möller HJ; Biersack HJ
Am J Psychiatry; 1996 Feb; 153(2):183-90. PubMed ID: 8561197
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of [123I]IBZM pinhole SPECT for the detection of striatal dopamine D2 receptor availability in rats.
Scherfler C; Scholz SW; Donnemiller E; Decristoforo C; Oberladstätter M; Stefanova N; Diederen E; Virgolini I; Poewe W; Wenning GK
Neuroimage; 2005 Feb; 24(3):822-31. PubMed ID: 15652317
[TBL] [Abstract][Full Text] [Related]
9. Striatal vs extrastriatal dopamine D2 receptors in antipsychotic response--a double-blind PET study in schizophrenia.
Agid O; Mamo D; Ginovart N; Vitcu I; Wilson AA; Zipursky RB; Kapur S
Neuropsychopharmacology; 2007 Jun; 32(6):1209-15. PubMed ID: 17077809
[TBL] [Abstract][Full Text] [Related]
10. Comfort, self-confidence, safety, and dopamine D2 receptor occupancy by antipsychotics.
de Haan L; Lavalaye J; Booij J; Linszen D
Am J Psychiatry; 2005 Aug; 162(8):1544-5. PubMed ID: 16055785
[No Abstract] [Full Text] [Related]
11. Striatal dopamine D2 receptor binding and dopamine release during cue-elicited craving in recently abstinent opiate-dependent males.
Zijlstra F; Booij J; van den Brink W; Franken IH
Eur Neuropsychopharmacol; 2008 Apr; 18(4):262-70. PubMed ID: 18077142
[TBL] [Abstract][Full Text] [Related]
12. D2-dopamine receptor occupancy measured by IBZM-SPECT in relation to extrapyramidal side effects.
Broich K; Grünwald F; Kasper S; Klemm E; Biersack HJ; Möller HJ
Pharmacopsychiatry; 1998 Sep; 31(5):159-62. PubMed ID: 9832346
[TBL] [Abstract][Full Text] [Related]
13. D2 receptor occupancy under recommended and high doses of olanzapine: an iodine-123-iodobenzamide SPECT study.
Meisenzahl EM; Dresel S; Frodl T; Schmitt GJ; Preuss UW; Rossmüller B; Tatsch K; Mager T; Hahn K; Möller HJ
J Psychopharmacol; 2000; 14(4):364-70. PubMed ID: 11198054
[TBL] [Abstract][Full Text] [Related]
14. Sertindole and dopamine D2 receptor occupancy in comparison to risperidone, clozapine and haloperidol - a 123I-IBZM SPECT study.
Kasper S; Tauscher J; Küfferle B; Barnas C; Hesselmann B; Asenbaum S; Podreka I; Brücke T
Psychopharmacology (Berl); 1998 Apr; 136(4):367-73. PubMed ID: 9600582
[TBL] [Abstract][Full Text] [Related]
15. Comparison between olanzapine and haloperidol on procedural learning and the relationship with striatal D2 receptor occupancy in schizophrenia.
Paquet F; Soucy JP; Stip E; Lévesque M; Elie A; Bédard MA
J Neuropsychiatry Clin Neurosci; 2004; 16(1):47-56. PubMed ID: 14990759
[TBL] [Abstract][Full Text] [Related]
16. Imaging of dopamine receptors with [123I]iodobenzamide single-photon emission-computed tomography in neuroleptic malignant syndrome.
Jauss M; Krack P; Franz M; Klett R; Bauer R; Gallhofer B; Dorndorf W
Mov Disord; 1996 Nov; 11(6):726-8. PubMed ID: 8914102
[TBL] [Abstract][Full Text] [Related]
17. In vivo (123)I IBZM SPECT imaging of striatal dopamine 2 receptor occupancy in schizophrenic patients.
Barnas C; Quiner S; Tauscher J; Hilger E; Willeit M; Küfferle B; Asenbaum S; Brücke T; Rao ML; Kasper S
Psychopharmacology (Berl); 2001 Sep; 157(3):236-42. PubMed ID: 11605078
[TBL] [Abstract][Full Text] [Related]
18. Dopamine D2 receptor occupancy by risperidone: implications for the timing and magnitude of clinical response.
Catafau AM; Corripio I; Pérez V; Martin JC; Schotte A; Carrió I; Alvarez E
Psychiatry Res; 2006 Dec; 148(2-3):175-83. PubMed ID: 17059881
[TBL] [Abstract][Full Text] [Related]
19. Subjective effects of AMPT-induced dopamine depletion in schizophrenia: correlation between dysphoric responses and striatal D(2) binding ratios on SPECT imaging.
Voruganti L; Slomka P; Zabel P; Costa G; So A; Mattar A; Awad AG
Neuropsychopharmacology; 2001 Nov; 25(5):642-50. PubMed ID: 11682247
[TBL] [Abstract][Full Text] [Related]
20. Occupancy of striatal and extrastriatal dopamine D2 receptors by clozapine and quetiapine.
Kessler RM; Ansari MS; Riccardi P; Li R; Jayathilake K; Dawant B; Meltzer HY
Neuropsychopharmacology; 2006 Sep; 31(9):1991-2001. PubMed ID: 16738543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
